Antheia Gains $9 Million to Reinforce Domestic Pharmaceutical Supply Chains Antheia announces an additional $9 million funding to bolster domestic pharmaceutical supply chains. This shows the U.S. commitment towards advanced pharmaceutical manufacturing.

Antheia Gains $9 Million to Reinforce Domestic Pharmaceutical Supply Chains #United_States #Menlo_Park #Biopharmaceutical #Antheia #BioMaP

Ginkgo Bioworks Engages in Innovative Monoclonal Antibody Development Under BARDA Partnership Ginkgo Bioworks has secured a significant contract under BARDA's BioMaP-Consortium to innovate monoclonal antibody production against filoviruses. This initiative aims at bolstering U.S. biosecurity.

Ginkgo Bioworks Engages in Innovative Monoclonal Antibody Development Under BARDA Partnership #United_States #Boston #Ginkgo_Bioworks #BARDA #BioMaP